Thomas M. Ross has sold MXCT and made no open-market buys since Nov 2021

Ross Thomas M. is an individual corporate executive who serves as executive vice president of global sales at MaxCyte, Inc., a role he has held since September 2014.( In this capacity, he oversees MaxCyte’s global commercial strategy and sales organization for its cell-engineering technologies, and is regularly identified in regulatory filings and trading records as EVP, GLOBAL SALES or EVP, GLOBAL SALES & MARKETING for the company.( He is also reported as a MaxCyte insider holding approximately 25,000 shares of the company’s stock.(

Before joining MaxCyte, Ross built an extensive career in life sciences and diagnostics commercial leadership. He previously served as senior vice president of commercial operations at OpGen from 2012 to 2014, chief commercial officer at Predictive BioScience, and vice president of North America medical diagnostics sales at Qiagen/Digene Corporation.( Earlier in his career, he held several senior manufacturing operations leadership roles at Life Technologies Corporation and Cambrex, giving him end‑to‑end experience across both operations and commercial functions in the biotechnology sector.( Ross holds a B.A. in business administration from The Citadel, providing a formal business foundation for his executive responsibilities.(

Written by Perplexity from public sources.